gastroparesis and tirzepatide A 32-year-old man developed after taking for weight loss, which isn't approved in India. Doctors advise against using it without medical supervision Diabetes and Gastroparesis: New Concepts

All trials reported that tirzepatide was superior to all alternatives at lowering glycated hemoglobin (HbA1c) levels

Diabetes Care ;47(Suppl 1):S52S76

Analyses of kidney outcomes in the original CVOTs prompted dedicated kidney outcome trials, of which two are completed: Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE, NCT02065791) and A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease (DAPA-CKD, NCT03036150)

Frequently Asked Questions How can I break through a weight loss plateau on semaglutide

The number of treatments required differs from person to person, depending on the area being treated and personal objectives